SAT0681 Risk of active tuberculosis in patients with inflammatory arthritis receiving tnf-inhibitors

Autor: A. Garaiman, D Bumbăcea, V Aramă, I. Ancuta, Mihai Bojinca, A. Martin, Rucsandra Dobrota, Liviu Macovei, Alina Soare, Ana Maria Gheorghiu, C. Ciofu, A Radu, C. Mihai, R. Oneata, S. Pintilie, M. Sasu, M. Milicescu, Victor Stoica

Publikováno v: Poster Presentations.

Background Tuberculosis (TB) is a major concern in patients receiving TNF inhibitors (TNFi). Objectives To assess the incidence of active TB and the efficacy of TB prevention measures in a large, single-center cohort of patients with rheumatoid arthr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cca83b1eeaaa0f7f10d6e7e165a10b5c
https://doi.org/10.1136/annrheumdis-2017-eular.5835

EFFICACY AND SAFETY OF GOLIMUMAB AS ADD-ON THERAPY TO DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS: RESULTS OF THE GO-MORE STUDY IN ROMANIA

Autor: Cluj-Napoca Pharmacy, Catalin Codreanu, Craiova Pharmacy, Simona Rednic, Anca Rosu, M. Suta, Iasi Pharmacy, Lorena Petcu, Rodica Chireac, I. Ancuta, Bucharest Pharmacy, M. Parvu, Ruxandra Ionescu, Merck Sharpe Dohme Romania, Bucharest, Romania

Publikováno v: Romanian Journal of Rheumatology. 24:207-213

Objectives. GO-MORE was an open-label, multinational, prospective observational study in patients with active rheumatoid arthritis (RA) in typical clinical practice settings in 40 countries. The trial involved patients with active rheumatoid arthriti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::974ab722d05abddafb81204cad752148
https://doi.org/10.37897/rjr.2015.4.4

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial

Autor: Roy Fleischmann, Eduardo Mysler, Stephen Hall, Alan J Kivitz, Robert J Moots, Zhen Luo, Ryan DeMasi, Koshika Soma, Richard Zhang, Liza Takiya, Svitlana Tatulych, Christopher Mojcik, Sriram Krishnaswami, Sujatha Menon, Josef S Smolen, Luthando Adams, Mahmood M Ally, Maria C du Plooy, Ingrid C Louw, Savithree Nayiager, Christoffel B Nel, Debra Nel, Helmuth Reuter, Ahmed S Soloman, Catherine E Spargo, Maureen Rischmueller, Shunil D Sharma, Robert K Will, Peter P Youssef, Caroline Arroyo, Rosario P Baes, Roger B Dulos, Llewellyn T Hao, Allan E Lanzon, Juan Javier T Lichauco, Jill H Mangubat, Edgar B Ramiterre, Bernadette Heizel M Reyes, Perry P Tan, Jung-Yoon Choe, Young Mo Kang, Seong Ryul Kwon, Sang-Heon Lee, Shin-Seok Lee, Dae-Hyun Yoo, Hsiao-Yi Lin, Shue-Fen Luo, Shih-Tzu Tsai, Wen-Chan Tsai, Jui-Cheng Tseng, Cheng-Chung C Wei, Paijit Asavatanabodee, Kanokrat Nantiruj, Surasak Nilganuwong, Parichat Uea-Areewongsa, Ljubinka Bozic Majstorovic, Suada Mulic Bacic, Anastas Z Batalov, Gabriela Georgieva-Slavcheva, Mariyana Mihailova, Nikolay G Nikolov, Dimitar P Penev, Yuliy A Spasov, Krasimira Stanimirova, Stoyan Todorov, Antoaneta R Toncheva, Nadezhda Yordanova, Zdenka Mosterova, Libor Novosad, Leona Prochazkova, Helena Stehlikova, Zuzana Stejfova, Natalia Kiseleva, Lea Pank, Triin Savi, Balbir-Gurman Alexandra, Howard Amital, Dror Mevorach, Itzhak A Rosner, Anna Mihailova, Evija Stumbra-Stumberga, Vida Basijokiene, Virginija Lietuvininkiene, Dalia Unikiene, Jan Brzezicki, Anna M Dudek, Maria B Glowacka-Kulesz, Barbara Grabowicz-Wasko, Sabina Hajduk-Kubacka, Joanna Hilt, Pawel Hrycaj, Slawomir Jeka, Renata Kolasa, Marek Krogulec, Hanna Mastalerz, Anna Olak-Popko, Elzbieta Owczarek, Zofia Ruzga, Alina Walczak, Codrina I Ancuta, Ioan Ancuta, Andra R Balanescu, Florian Berghea, Silvia Bojin, Mihaela A Ianuli Arvunescu, Ruxandra M Ionescu, Eugenia Mociran, Mariana Pavel, Simona Rednic, Adriana Voie, Carmen M Zainea, Olga V Bugrova, Alexander Demin, Olga B Ershova, Inna A Gavrisheva, Diana G Krechikova, Gennady V Kuropatkin, Irina M Marusenko, Irina V Menshikova, Sergey M Noskov, Andrey P Rebrov, Svetlana A Smakotina, Sergey S Yakushin, Evgeny Zhilyaev, Juan Jose Amarelo Ramos, Francisco Javier Blanco Garcia, Antonio Fernandez Nebro, Silvia Perez Esteban, Juan Miguel Sanchez Burson, Raimon Sanmarti Sala, Sebnem Ataman, Sami Hizmetli, Omer Kuru, Karen M Douglas, Paul Emery, Voon H Ong, Thomas P Sheeran, Rafat Y Faraawi, Clode Lessard, Carlos Abud Mendoza, Hilario Ernesto Avila-Armengol, Francisco I Avila Zapata, Fedra Consuelo Irazoque-Palazuelos, Marco Antonio Maradiaga Cecena, Cesar F Pacheco-Tena, Juan C Rizo-Rodriguez, Isaura M Rodriguez-Torres, Jacob A Aelion, Barbara A Caciolo, James M Calmes, Prem Chatpar, Nimesh Dayal, Alex De Jesus, Ara H Dikranian, Erdal Diri, Michael J Fairfax, Ira F Fenton, Roy M Fleischmann, Norman B Gaylis, Ronald L George, Dale G Halter, Paul Hernandez, Susan A Hole, Antony C Hou, John P Huff, Suzanne Kafaja, Alastair C Kennedy, Howard Kenney, Steven C Kimmel, Brian S Kirby, Clarence W Legerton, Stephen M Lindsey, Jyothi R Mallepalli, Steven D Mathews, Samy K Metyas, Wesley T Mizutani, Sabeen Najam, Joao M Nascimento, Shirley W Pang, Rakesh C Patel, Jeffrey E Poiley, Carlos E Ramirez, Riteesha Reddy, Qaiser Rehman, William M Schnitz, Craig D Scoville, William J Shergy, Joel C Silverfield, Atul K Singhal, Yvonne R Smallwood-Sherrer, Suthin N Songcharoen, Michael T Stack, William Stohl, Tien-I K Su, James Udell, Saleem Waraich, Charles E Weidmann, Nathan Wei, Craig W Wiesenhutter, Anne E Winkler, Karen E Zagar, Alberto Berman, Eduardo F Mysler, Rodolfo A Pardo Hidalgo, Horacio O Venarotti, Irmgadt Annelise Goecke Sariego, Renato E Jimenez Calabresse, Juan Ignacio Vargas Ruiz-Tagle, Luis Fernando M Bellatin Vargas, Alfredo E Berrocal, Manuel Gustavo Leon Portocarrero, Felix Jesus, Romero Pena

Publikováno v: LANCET

Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy aimed to assess the comparative efficacy of tofacitinib monotherapy, tofacitinib plus meth

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8d20ced5063ec70967b828d0b5d348d
https://pubmed.ncbi.nlm.nih.gov/28680135

Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration

Autor: Ronald F van Vollenhoven, Galina Lukina, Juan J. Gomez-Reino, Karel Pavelka, Matija Tomšič, Tore K Kvien, Elisabeth Lie, Ziga Rotar, Merete Lund Hetland, I. Ancuta, Almut Scherer, Maria José Santos, M. Victoria Hernández, Dan Nordström, Ellen Margrethe Hauge, Katerina Chatzidionysiou, Helena Canhão, Cem Gabay

Publikováno v: Journal of rheumatology, 44(2), 162-169. Journal of Rheumatology
Chatzidionysiou, K, Lie, E, Lukina, G, Hetland, M L, Hauge, E-M, Pavelka, K, Gabay, C, Nordström, D, Canhao, H, Santos, M J, Tomsic, M, Rotar, Z, Hernández, M V, Gomez-Reino, J, Ancuta, I, Kvien, T K & van Vollenhoven, R 2017, ' Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort : Data from the CERERRA Collaboration ', Journal of Rheumatology, vol. 44, no. 2, pp. 162-169 . https://doi.org/10.3899/jrheum.160460
Chatzidionysiou, K, Lie, E, Lukina, G, Hetland, M L, Hauge, E M, Pavelka, K, Gabay, C, Scherer, A, Nordström, D, Canhao, H, Santos, M J, Tomsic, M, Rotar, Z, Hernández, M V, Gomez-Reino, J, Ancuta, I, Kvien, T K & Van Vollenhoven, R 2017, ' Rituximab retreatment in rheumatoid arthritis in a real-life cohort : Data from the CERERRA collaboration ', Journal of Rheumatology, vol. 44, no. 2, pp. 162-169 . https://doi.org/10.3899/jrheum.160460
Journal of Rheumatology, 44(2), 162-169. Journal of Rheumatology
Journal of Rheumatology, Vol. 44, No 2 (2017) pp. 162-169

Objective.Several aspects of rituximab (RTX) retreatment in rheumatoid arthritis (RA) need to be further elucidated. The aim of this study was to describe the effect of repeated courses of RTX on disease activity and to compare 2 retreatment strategi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36e8ff7488a0c14ba90dff3aa059d208
https://pure.amc.nl/en/publications/rituximab-retreatment-in-rheumatoid-arthritis-in-a-reallife-cohort-data-from-the-cererra-collaboration(a154340d-6859-4935-b27e-9c90462b367f).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.